PerkinG.S., ToddG.M., BrownT.M.. Jet Injection of insulin in the treatment of Diabetes Mellitus.Proc Diabetes Assoc1950; 10: 184–99.
2.
American Diabetes Association.Position statement on Jet Injectors.Diabetes Care1988; 11: 600–1.
3.
LindmayerI., MenassaK., LambertJ.. Development of new jet injector for insulin therapy.Diabetes Care1986; 9: 294–7.
4.
PehlingG.B., GerichJ.E.. Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle in patients with insulin-dependent diabetes mellitus.Mayo Clin proc1984; 59: 751–4.
5.
TaylorR., HomeP.D., AlbertiKGMM. Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection.Diabetes Care1981; 4: 377–9.
6.
MaloneJl, LowittS., GroveN.P., ShahS.C.. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.Diabetes Care1986; 9: 637–40.
7.
HontzagersC., BerntzenP.A., Van der StapH.. Absorption kinetics of short and intermediate acting insulins after jet injection with Medi-Jector II.Diabetes Care1988; 11: 739–42.
8.
KatoulisE.C., DrosinosE.K., DimitriadisG.K.. Efficacy of a new needleless insulin delivery system. Monitoring of blood glucose fluctuations and free insulin levels.Int J Artif Organs1989; 12: 333–8.
9.
Jovanovic-PetersenL., PalmerJ.P., SparksS., PetersonC.M.. Jet-injected insulin is associated with decreased antibody production and postprandial glucose variability when compared with needle-injected insulin in gestational diabetic women.Diabetes Care1993; 16(11): 1479–84.
10.
KessonC.M., BaillieG.R.. Do diabetic patients inject accurate doses of insulin.Diabetes Care1981; 4: 333–6.
11.
CartwrightB.J., GerlisL.S., OwensC.. Will the change to U-100 insulin affect diabetic control.Lancet1983; 1: 828–9.
Dahl-JorgensenK., HanssenK.F., MosandR., SandvikL.. The pen injector: comparison with multiple injection treatment with syringe.Practical Diabetes1986; 3: 90–1.
14.
DistillerL.A., RobertsonL.I., MooreR., BonniciF.. A bolus/basal multiple injection regimen in type I Diabetes.S Afr Med J1987; 71: 749–52.
15.
JensenT.. The Basal/bolus strategy and novopen TM.Novo Annual report1985; 12–7.
16.
McCaugheyE.S., BettsP.R., RoweD.J.. Improved diabetic control in adolescents using the penject syringe for multiple insulin injections.Diabetic Medicine1986; 3: 234–6.
17.
Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development of long-term complications in insulin dependent diabetes mellitus.N Engl J Med1993; 329: 977–86.
18.
Dahl-JorgensenK., Brinchmann-HansenO., BangstadH.J., HanssenK.F.. Blood glucose control and microvascular complications what do we do now?Diabetologia1994; 37: 1172–7.
19.
Roe-Finlay-Dean.Insulin pen-injector systems in adolescents with IDDM.Diabetes Care1990; 13: 78–9.
